Skip to main content
Erschienen in: Surgery Today 9/2013

01.09.2013 | Original Article

The use of the continuous suture technique in dunking pancreatojejunostomy without stenting

verfasst von: Tomoe Katoh, Kazuaki Kawano, Akira Furutani, Takefumi Katsuki, Masahiko Onoda, Atsunori Oga

Erschienen in: Surgery Today | Ausgabe 9/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the newly developed continuous suture technique in dunking pancreatojejunostomy without pancreatic duct stenting after pancreatoduodenectomy (PD).

Methods

Thirty-four consecutive pancreaticojejunostomies (patient age 73 ± 11, 41–88) with continuous sutures without stenting after PD were performed from 2006 to 2011. This study evaluated the operation time, intraoperative blood loss, initial postoperative day of oral feeding, postoperative hospital stay, postoperative early complications, and late complications. The indications for surgery included bile duct cancer (n = 12), pancreatic cancer (n = 11), intraductal papillary mucinous neoplasm (n = 3), cancer of the papilla (n = 3), duodenal cancer (n = 2), and others (n = 3). Portal vein or superior mesenteric vein resections and reconstructions were performed in 7 patients, and another organ was resected in 3.

Results

No operative or in-hospital deaths occurred. The operation time (minutes) was 315 ± 68 and, postoperative hospital stay (days) was 27 ± 16. Pancreatic fistula, wound infection, and delayed gastric emptying were observed in 15, 15, and 9 %, respectively. Grade C pancreatic fistula was seen in 2 patients. Both recovered after laparotomy and drainage and were successfully discharged. Worsening diabetes mellitus was seen in 2 of 34 patients, and dilatation of the pancreatic duct was seen in 3 of 28 patients.

Conclusion

The newly developed continuous suture technique in dunking pancreatojejunostomy without stenting may therefore produce favorable results in PD.
Literatur
1.
Zurück zum Zitat Hashimoto D, Takamori H, Sakamoto Y, Ikuta Y, Nakahara O, Furuhashi S, et al. Is an estimation of physiologic ability and surgical stress able to predict operative morbidity after pancreaticoduodenectomy? J Hepatobiliary Pancreat Sci. 2010;17:132–8.PubMedCrossRef Hashimoto D, Takamori H, Sakamoto Y, Ikuta Y, Nakahara O, Furuhashi S, et al. Is an estimation of physiologic ability and surgical stress able to predict operative morbidity after pancreaticoduodenectomy? J Hepatobiliary Pancreat Sci. 2010;17:132–8.PubMedCrossRef
2.
Zurück zum Zitat Yeo CJ, Cameron JL, Maher MM, Sauter PK, Zahurak ML, Talamini MA, et al. A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg. 1995;222:580–92.PubMed Yeo CJ, Cameron JL, Maher MM, Sauter PK, Zahurak ML, Talamini MA, et al. A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg. 1995;222:580–92.PubMed
3.
Zurück zum Zitat Cunningham JD, O’Donnell N, Starker P. Surgical outcomes following pancreatic resection at a low-volume community hospital: do all patients need to be sent to a regional cancer center? Am J Surg. 2009;198:227–30.PubMedCrossRef Cunningham JD, O’Donnell N, Starker P. Surgical outcomes following pancreatic resection at a low-volume community hospital: do all patients need to be sent to a regional cancer center? Am J Surg. 2009;198:227–30.PubMedCrossRef
4.
Zurück zum Zitat Sohn TA, Yeo CJ, Cameron JL, Geschwind JF, Mitchell SE, Venbrux AC, et al. Pancreaticoduodenectomy: role of interventional radiologists in managing patients and complications. J Gastrointest Surg. 2003;7:209–19.PubMedCrossRef Sohn TA, Yeo CJ, Cameron JL, Geschwind JF, Mitchell SE, Venbrux AC, et al. Pancreaticoduodenectomy: role of interventional radiologists in managing patients and complications. J Gastrointest Surg. 2003;7:209–19.PubMedCrossRef
5.
Zurück zum Zitat Watanabe M, Usui S, Kajiwara H, Nakamura M, Sumiyama Y, Takada T, et al. Current pancreatogastrointestinal anastomotic methods: results of a Japanese survey of 3109 patients. J Hepatobiliary Pancreat Surg. 2004;11:25–33.PubMedCrossRef Watanabe M, Usui S, Kajiwara H, Nakamura M, Sumiyama Y, Takada T, et al. Current pancreatogastrointestinal anastomotic methods: results of a Japanese survey of 3109 patients. J Hepatobiliary Pancreat Surg. 2004;11:25–33.PubMedCrossRef
6.
Zurück zum Zitat Yokoyama Y, Nimura Y, Nagino M. Advances in the treatment of pancreatic cancer: limitations of surgery and evaluation of new therapeutic strategies. Surg Today. 2009;39:466–75.PubMedCrossRef Yokoyama Y, Nimura Y, Nagino M. Advances in the treatment of pancreatic cancer: limitations of surgery and evaluation of new therapeutic strategies. Surg Today. 2009;39:466–75.PubMedCrossRef
7.
Zurück zum Zitat Fernández-Cruz L, Belli A, Acosta M, Chavarria EJ, Adelsdorfer W, López-Boado MA, et al. Which is the best technique for pancreaticoenteric reconstruction after pancreaticoduodenectomy? A critical analysis. Surg Today. 2011;41:761–6.PubMedCrossRef Fernández-Cruz L, Belli A, Acosta M, Chavarria EJ, Adelsdorfer W, López-Boado MA, et al. Which is the best technique for pancreaticoenteric reconstruction after pancreaticoduodenectomy? A critical analysis. Surg Today. 2011;41:761–6.PubMedCrossRef
8.
Zurück zum Zitat Hashimoto Y, Traverso LM. Incidence of pancreatic anastomotic failure and delayed gastric emptying after pancreatoduodenectomy in 507 consecutive patients: use of a web-based calculator to improve homogeneity of definition. Surgery. 2010;147:503–15.PubMedCrossRef Hashimoto Y, Traverso LM. Incidence of pancreatic anastomotic failure and delayed gastric emptying after pancreatoduodenectomy in 507 consecutive patients: use of a web-based calculator to improve homogeneity of definition. Surgery. 2010;147:503–15.PubMedCrossRef
9.
Zurück zum Zitat Schnelldorfer T, Reid-Lombardo K, Sarr MG. Development of pancreatoduodenectomy in North America. Surg Today. 2011;41:377–81.PubMedCrossRef Schnelldorfer T, Reid-Lombardo K, Sarr MG. Development of pancreatoduodenectomy in North America. Surg Today. 2011;41:377–81.PubMedCrossRef
10.
Zurück zum Zitat Schlitt HJ, Schmidt U, Simunec D, Jaeger M, Aselmann H, Neipp M, et al. Morbidity and mortality associated with pancreatogastrostomy and pancreatojejunostomy following partial pancreatoduodenectomy. Br J Surg. 2002;89:1245–51.PubMedCrossRef Schlitt HJ, Schmidt U, Simunec D, Jaeger M, Aselmann H, Neipp M, et al. Morbidity and mortality associated with pancreatogastrostomy and pancreatojejunostomy following partial pancreatoduodenectomy. Br J Surg. 2002;89:1245–51.PubMedCrossRef
11.
Zurück zum Zitat Aranha GV, Hodul P, Golts E, Daniel O, Pikleman J, Creech S. A comparison of pancreaticogastrostomy and pancreaticojejunostomy following pancreaticoduodenectomy. J Gastrointest Surg. 2003;7:672–82.PubMedCrossRef Aranha GV, Hodul P, Golts E, Daniel O, Pikleman J, Creech S. A comparison of pancreaticogastrostomy and pancreaticojejunostomy following pancreaticoduodenectomy. J Gastrointest Surg. 2003;7:672–82.PubMedCrossRef
12.
Zurück zum Zitat Satoi S, Toyokawa H, Yanagimoto H, Yamamoto T, Yamao J, Kim S, et al. A new guideline to reduce postoperative morbidity after pancreaticoduodenectomy. Pancreas. 2008;37:128–33.PubMedCrossRef Satoi S, Toyokawa H, Yanagimoto H, Yamamoto T, Yamao J, Kim S, et al. A new guideline to reduce postoperative morbidity after pancreaticoduodenectomy. Pancreas. 2008;37:128–33.PubMedCrossRef
13.
Zurück zum Zitat Imaizumi T, Hatori T, Tobita K, Fukuda A, Takahashi K, Makuuchi H. Pancreaticojejunostomy using duct-to-mucosa anastomosis without a stenting tube. J Hepatobiliary Pancreat Surg. 2006;13:194–201.PubMedCrossRef Imaizumi T, Hatori T, Tobita K, Fukuda A, Takahashi K, Makuuchi H. Pancreaticojejunostomy using duct-to-mucosa anastomosis without a stenting tube. J Hepatobiliary Pancreat Surg. 2006;13:194–201.PubMedCrossRef
14.
Zurück zum Zitat Suzuki Y, Fujino Y, Ajiki T, Ueda T, Sakai T, Tanioka Y, et al. No mortality among 100 consecutive pancreaticoduodenectomies in a middle-volume canter. World J Surg. 2005;29:1409–14.PubMedCrossRef Suzuki Y, Fujino Y, Ajiki T, Ueda T, Sakai T, Tanioka Y, et al. No mortality among 100 consecutive pancreaticoduodenectomies in a middle-volume canter. World J Surg. 2005;29:1409–14.PubMedCrossRef
15.
Zurück zum Zitat Yang YL, Xu XP, Wu GQ, Yue SQ, Dou KF. Prevention of pancreatic leakage after pancreaticoduodenectomy by modified Child pancreaticojejunostomy. Hepatobiliary Pancreat Dis Int. 2008;7:426–9.PubMed Yang YL, Xu XP, Wu GQ, Yue SQ, Dou KF. Prevention of pancreatic leakage after pancreaticoduodenectomy by modified Child pancreaticojejunostomy. Hepatobiliary Pancreat Dis Int. 2008;7:426–9.PubMed
16.
Zurück zum Zitat Peng SY, Wang JW, Lau WY, Cai XJ, Mou YP, Liu YB, et al. Conventional versus binding pancreaticojejunostomy after pancreaticoduodenectomy—a prospective randomized trial. Ann Surg. 2007;245:692–8.PubMedCrossRef Peng SY, Wang JW, Lau WY, Cai XJ, Mou YP, Liu YB, et al. Conventional versus binding pancreaticojejunostomy after pancreaticoduodenectomy—a prospective randomized trial. Ann Surg. 2007;245:692–8.PubMedCrossRef
17.
Zurück zum Zitat Kimura W. Strategies for the treatment of invasive ductal carcinoma of the pancreas and how to achieve zero mortality for pancreaticoduodenectomy. J Hepatobiliary Pancreat Surg. 2008;15:270–7.PubMedCrossRef Kimura W. Strategies for the treatment of invasive ductal carcinoma of the pancreas and how to achieve zero mortality for pancreaticoduodenectomy. J Hepatobiliary Pancreat Surg. 2008;15:270–7.PubMedCrossRef
18.
Zurück zum Zitat Winter JM, Cameron JL, Campbell KA, Chang DC, Riall TS, Schulick RD, et al. Does pancreatic duct stenting decrease the rate of pancreatic fistula following pancreaticoduodenectomy? Results of a postoperative randomized trial. J Gastrointest Surg. 2006;10:1280–90.PubMedCrossRef Winter JM, Cameron JL, Campbell KA, Chang DC, Riall TS, Schulick RD, et al. Does pancreatic duct stenting decrease the rate of pancreatic fistula following pancreaticoduodenectomy? Results of a postoperative randomized trial. J Gastrointest Surg. 2006;10:1280–90.PubMedCrossRef
19.
Zurück zum Zitat Traverso LW, Hashimoto Y. Delayed gastric emptying: the state of the highest level of evidence. J Hepatobiliary Pancreat Surg. 2008;15:262–9.PubMedCrossRef Traverso LW, Hashimoto Y. Delayed gastric emptying: the state of the highest level of evidence. J Hepatobiliary Pancreat Surg. 2008;15:262–9.PubMedCrossRef
20.
Zurück zum Zitat Murakami H, Suzuki H, Nakamura T. Pancreatic fibrosis correlates with delayed gastric empting after pylorus-preserving pancreaticoduodenectomy with pancreaticogastrostomy. Ann Surg. 2002;235:240–5.PubMedCrossRef Murakami H, Suzuki H, Nakamura T. Pancreatic fibrosis correlates with delayed gastric empting after pylorus-preserving pancreaticoduodenectomy with pancreaticogastrostomy. Ann Surg. 2002;235:240–5.PubMedCrossRef
21.
Zurück zum Zitat Ueno T, Takashima M, Iida M, Yoshida S, Suzuki N, Oka M. Improvement of delayed gastric emptying in patients with Billroth I type of reconstruction after pylorus preserving pancreatoduodenectomy. J Hepatobiliary Pancreat Surg. 2009;16:300–4.PubMedCrossRef Ueno T, Takashima M, Iida M, Yoshida S, Suzuki N, Oka M. Improvement of delayed gastric emptying in patients with Billroth I type of reconstruction after pylorus preserving pancreatoduodenectomy. J Hepatobiliary Pancreat Surg. 2009;16:300–4.PubMedCrossRef
22.
Zurück zum Zitat Tani M, Terasawa H, Kawai M, Ina S, Hirono S, Uchiyama K, et al. Improvement of delayed gastric emptying in pylorus-preserving pancreaticoduodenectomy. Results of a prospective, randomized, controlled trial. Ann Surg. 2006;243:316–20.PubMedCrossRef Tani M, Terasawa H, Kawai M, Ina S, Hirono S, Uchiyama K, et al. Improvement of delayed gastric emptying in pylorus-preserving pancreaticoduodenectomy. Results of a prospective, randomized, controlled trial. Ann Surg. 2006;243:316–20.PubMedCrossRef
23.
Zurück zum Zitat Kurosaki I, Hatakeyama K. Clinical and surgical factors influencing delayed gastric emptying after pyloric-preserving pancreaticoduodenectomy. Hepatogastroenterology. 2005;52:143–8.PubMed Kurosaki I, Hatakeyama K. Clinical and surgical factors influencing delayed gastric emptying after pyloric-preserving pancreaticoduodenectomy. Hepatogastroenterology. 2005;52:143–8.PubMed
Metadaten
Titel
The use of the continuous suture technique in dunking pancreatojejunostomy without stenting
verfasst von
Tomoe Katoh
Kazuaki Kawano
Akira Furutani
Takefumi Katsuki
Masahiko Onoda
Atsunori Oga
Publikationsdatum
01.09.2013
Verlag
Springer Japan
Erschienen in
Surgery Today / Ausgabe 9/2013
Print ISSN: 0941-1291
Elektronische ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-012-0363-x

Weitere Artikel der Ausgabe 9/2013

Surgery Today 9/2013 Zur Ausgabe

Leitlinien kompakt für die Allgemeinmedizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Facharzt-Training Allgemeinmedizin

Die ideale Vorbereitung zur anstehenden Prüfung mit den ersten 24 von 100 klinischen Fallbeispielen verschiedener Themenfelder

Mehr erfahren

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Isotretinoin: Risiko für schwere Laboranomalien „marginal erhöht“

08.05.2024 Akne Nachrichten

Die Aknetherapie mit Isotretinoin kann einen Anstieg von Leberenzymen und Blutfetten verursachen. Das Risiko für schwere Störungen ist laut einer Forschungsgruppe der Universität Lübeck aber nur marginal erhöht und auf einen engen Zeitraum konzentriert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Allgemeinmedizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.